FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula (I) where values of the substitutes are disclosed in the patent claim.
EFFECT: compounds can be applied for treating the infections caused by Pneumovirinae subfamily viruses (RSV, PCB).
53 cl, 502 ex, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | 2008 |
|
RU2490265C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
IDO INHIBITORS | 2012 |
|
RU2613579C2 |
PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
DERIVATIVES OF TETRAHYDROIMIDAZO[2,1-A]ISO- QUINOLINE AND PHARMACEUTICAL PREPARATION BASED ON THEREOF | 1998 |
|
RU2204560C2 |
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
OCTAHYDROPENTALENE COMPOUNDS AS CHEMOKINE RECEPTOR ANTAGONISTS | 2008 |
|
RU2481332C2 |
PYRIMIDINE DERIVATIVES WITH ANTAGONIST PROPERTIES TOWARDS CRTH2(VERSIONS) | 2004 |
|
RU2361865C2 |
Authors
Dates
2011-06-27—Published
2004-12-24—Filed